Company Overview of Charterhouse Capital Partners LLP
Charterhouse Capital Partners LLP is a private equity and venture capital firm specializing in buyout investments, seed/startup, growth capital, and turnarounds. The firm prefers to invest in all sectors with a focus on industrial and commercial sectors with a focus on business service companies, financial services, leisure, support services, healthcare, telephone and telecommunications equipment, pharmaceuticals, biotechnology and life sciences, retailing, media, leisure products, outsourced business services, engineering services, chemicals, and consumer brands. It targets companies based in Europe with a focus on Western Europe, Northern Europe, and Continental Europe with a focus on Unit...
London, EC4M 7DX
Founded in 1934
Key Executives for Charterhouse Capital Partners LLP
Chief Executive Officer and Executive Chairman
Investor Relations Director
Compensation as of Fiscal Year 2015.
Charterhouse Capital Partners LLP Key Developments
Blackstone And CVC Reportedly Shown Interest In Acquiring Doc Generici From Charterhouse
Feb 1 16
Charterhouse Capital Partners LLP has hired London-based L.E.K. Consulting to provide strategic advice ahead of a possible sale of Doc Generici s.r.l., the report said. Doc Generici, based in Milan, could be valued at between €650 million and €700 million, the report added. The Blackstone Group L.P. (NYSE:BX) and CVC Capital Partners Limited are among the buyout funds that have already shown interest in taking part in the auction.
Charterhouse Reportedly Seeks Sale Of Doc Generici
Dec 2 15
Charterhouse Capital Partners LLP has hired L.E.K. Consulting LLP to provide strategic advice to Doc Generici which could lead to a sale next year, sources familiar with the matter said. Charterhouse has tested appetite from potential suitors in recent weeks and will meet with investment banks early next year to take a final decision on the sale, which could be launched after the summer. Prospective bidders could either wait for an auction to kick off in the second half of next year or talk directly with the seller to preempt the process. The business has already drawn interest from buyout funds Blackstone (BX.N) and CVC (CVC.UL) among a series of investment firms that are looking to take part in any auction. Charterhouse declined to comment while Doc Generici and L.E.K. had no immediate comment. Blackstone and CVC declined to comment.
Investors Reportedly Seeks Acquisition Of Stakes In Armacell
Nov 18 15
Investors reportedly seeks acquisition of stakes in Armacell GmbH. Charterhouse Capital Partners LLP has set a November 18, 2015, deadline for bids for Armacell GmbH, which could be worth up to €1 billion, people familiar with its plans said. Armacell has attracted interest from other private equity groups, the sources said, with The Blackstone Group L.P. (NYSE:BX), The Carlyle Group LP (NasdaqGS:CG), CVC Capital Partners Limited, KKR & Co. L.P. (NYSE:KKR) or TowerBrook Capital Partners L.P. cited as potential bidders, as well as industrial groups, the sources said. The company could be worth up to 10 times its expected core earnings this year of roughly €100 million euros, one source said, while others said a earnings multiple of 8-9 times core earnings was a more likely valuation. After initially launching preparations for a stock market listing of Armacell last year, Charterhouse recently opted for a sales process led by Rothschild Inc.Charterhouse, Rothschild and the other private equity groups declined to comment, except for CVC, which was not immediately available for comment.
Similar Private Companies By Industry
Recent Private Companies Transactions